JS Paikin, DS Wright… - Blood Reviews, 2011 - Elsevier Antiplatelet and anticoagulant drugs are effective for the prevention of arterial and venous thrombosis but patients continue to experience major cardiovascular events despite their use. Strategies to improve the effectiveness of antithrombotic therapies include selecting the optimal drug ... Cited by 1 - Related articles - All 3 versions
JW Eikelboom, L Wallentin, SJ Connolly… - Circulation, 2011 - Am Heart Assoc Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone: 410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division of Wolters ... Risk of Bleeding With 2 Doses of Dabigatran Compared Cited by 11 - Related articles - All 2 versions
[HTML] from hematologylibrary.orgMJ Flick, AK Chauhan, M Frederick… - …, 2011 - bloodjournal.hematologylibrary.org Thrombin is a positive mediator of thrombus formation through the proteolytic activation of protease-activated receptors (PARs), fibrinogen, factor XI (fXI), and other substrates, and a negative regulator through activation of protein C, a natural anticoagulant with anti-inflammatory/ ... Cited by 2 - Related articles - All 3 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
